Clinical Trial Update: A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany

View source ↗

Summary

Clinical trial update for Deucravacitinib in adults with moderate-to-severe plaque psoriasis in Germany; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Plaque Psoriasis | Status: ACTIVE_NOT_RECRUITING